Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Romanelli

Showing results (291-300 of 310) with videos related to

Pageof 31
Sort By:
BMC Health Services Research|September 7, 2021
A real-world economic analysis of biologic therapies for moderate-to-severe plaque psoriasis in Italy: results of the CANOVA observational longitudinal studyEmanuela Zagni, Luca Bianchi, Gabriella Fabbrocini, et al.
Dermatologic Therapy|October 22, 2021
Real-world evidence of biologic treatments in moderate-severe psoriasis in Italy: Results of the CANOVA (EffeCtiveness of biologic treAtmeNts for plaque psOriasis in Italy: An obserVAtional longitudinal study of real-life clinical practice) studyDelia Colombo, Luca Bianchi, Gabriella Fabbrocini, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 11, 2024
Age affects drug survival rates of interleukin (IL)-17 and IL-23 inhibitors in patients with plaque psoriasis: Results from a retrospective, multicentric, multi-country, cohort studyAndrea Chiricozzi, Giulia Coscarella, Luis Puig, et al.
Dermatology Practical & Conceptual|April 14, 2025
Enhancing Skin Cancer Prevention and Awareness in the Italian Population: Insights from the "Save Your Skin" Screening CampaignPaola Savoia, Laura Cristina Gironi, Chiara Airoldi, et al.
European Journal of Dermatology : EJD|November 24, 2025
From north to south: exploring Italian sun-exposure habits through the "Save your skin" campaignElisa Zavattaro, Chiara Airoldi, Federica Veronese, et al.
Clinical Rheumatology|November 6, 2020
Management of psoriatic arthritis in rheumatology and dermatology settings: sub-analysis of the Italian population from the international LOOP studyEnnio Lubrano, Andrea Delle Sedie, Marco Romanelli, et al.
Allergy|June 21, 2021
Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: Data from the DA-COVID-19 registryAndrea Chiricozzi, Marina Talamonti, Clara De Simone, et al.
Clinical and Experimental Dermatology|June 11, 2025
Effectiveness and Safety of Upadacitinib in Patients with Moderate-to-Severe Atopic Dermatitis and Previous Failures of Th2 Biologics: A Propensity Score-Matched StudyFrancesca Barei, Alessandra Chiei-Gallo, Alessandra Narcisi, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|February 7, 2022
Patients Withdrawing Dupilumab Monotherapy for COVID-19-Related Reasons Showed Similar Disease Course Compared With Patients Continuing Dupilumab TherapyAndrea Chiricozzi, Lucia Di Nardo, Marina Talamonti, et al.
Clinical and Experimental Dermatology|July 9, 2026
Real-Life Effectiveness and Safety of Lebrikizumab in Elderly Patients with Atopic Dermatitis: A Multicenter StudyMaddalena Napolitano, Giuseppe Lauletta, Marianna Cimmino, et al.
Pageof 31

Showing results (291-300 of 310) with videos related to

Sort By:
Pageof 31
BMC Health Services Research|September 7, 2021
A real-world economic analysis of biologic therapies for moderate-to-severe plaque psoriasis in Italy: results of the CANOVA observational longitudinal studyEmanuela Zagni, Luca Bianchi, Gabriella Fabbrocini, et al.
Dermatologic Therapy|October 22, 2021
Real-world evidence of biologic treatments in moderate-severe psoriasis in Italy: Results of the CANOVA (EffeCtiveness of biologic treAtmeNts for plaque psOriasis in Italy: An obserVAtional longitudinal study of real-life clinical practice) studyDelia Colombo, Luca Bianchi, Gabriella Fabbrocini, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 11, 2024
Age affects drug survival rates of interleukin (IL)-17 and IL-23 inhibitors in patients with plaque psoriasis: Results from a retrospective, multicentric, multi-country, cohort studyAndrea Chiricozzi, Giulia Coscarella, Luis Puig, et al.
Dermatology Practical & Conceptual|April 14, 2025
Enhancing Skin Cancer Prevention and Awareness in the Italian Population: Insights from the "Save Your Skin" Screening CampaignPaola Savoia, Laura Cristina Gironi, Chiara Airoldi, et al.
European Journal of Dermatology : EJD|November 24, 2025
From north to south: exploring Italian sun-exposure habits through the "Save your skin" campaignElisa Zavattaro, Chiara Airoldi, Federica Veronese, et al.
Clinical Rheumatology|November 6, 2020
Management of psoriatic arthritis in rheumatology and dermatology settings: sub-analysis of the Italian population from the international LOOP studyEnnio Lubrano, Andrea Delle Sedie, Marco Romanelli, et al.
Allergy|June 21, 2021
Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: Data from the DA-COVID-19 registryAndrea Chiricozzi, Marina Talamonti, Clara De Simone, et al.
Clinical and Experimental Dermatology|June 11, 2025
Effectiveness and Safety of Upadacitinib in Patients with Moderate-to-Severe Atopic Dermatitis and Previous Failures of Th2 Biologics: A Propensity Score-Matched StudyFrancesca Barei, Alessandra Chiei-Gallo, Alessandra Narcisi, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|February 7, 2022
Patients Withdrawing Dupilumab Monotherapy for COVID-19-Related Reasons Showed Similar Disease Course Compared With Patients Continuing Dupilumab TherapyAndrea Chiricozzi, Lucia Di Nardo, Marina Talamonti, et al.
Clinical and Experimental Dermatology|July 9, 2026
Real-Life Effectiveness and Safety of Lebrikizumab in Elderly Patients with Atopic Dermatitis: A Multicenter StudyMaddalena Napolitano, Giuseppe Lauletta, Marianna Cimmino, et al.
Pageof 31